Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin
- PMID: 7505976
Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin
Abstract
Prostate specific antigen is an abundant prostate-derived serine protease in the seminal fluid. Low concentrations of the protein are normally released into blood, but above normal concentrations are frequently detected in prostate disease. The PSA-ACT complex is the predominant molecular form of serum PSA (up to approximately 95%) although complex formation is slow between the purified proteins in vitro. A free, noncomplexed form of PSA constitutes a minor fraction of the serum PSA, although serum ACT occurs in large molar excess. The free, noncomplexed form of serum PSA is reported to constitute a significantly smaller proportion of the PSA in untreated prostate cancer than in BPH. The molecular basis for this finding is unclear, but measurements of the proportion of the free form of serum PSA or the proportion of serum PSA-ACT may facilitate discrimination between prostate cancer and BPH.
Similar articles
-
Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.Scand J Clin Lab Invest Suppl. 1995;220:47-56. Scand J Clin Lab Invest Suppl. 1995. PMID: 7544478
-
Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.J Urol. 1993 Jul;150(1):100-5. doi: 10.1016/s0022-5347(17)35408-3. J Urol. 1993. PMID: 7685416
-
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.Cancer. 1998 Dec 15;83(12):2540-7. Cancer. 1998. PMID: 9874461
-
[Molecular forms of prostate-specific antigen and their clinical significance].Urologe A. 1995 Jul;34(4):275-82. Urologe A. 1995. PMID: 7545841 Review. German.
-
Prostate-specific antigen.Semin Cancer Biol. 1999 Apr;9(2):83-93. doi: 10.1006/scbi.1998.0086. Semin Cancer Biol. 1999. PMID: 10202130 Review.
Cited by
-
[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.J Urol. 2010 Apr;183(4):1355-9. doi: 10.1016/j.juro.2009.12.056. Epub 2010 Feb 19. J Urol. 2010. PMID: 20171670 Free PMC article.
-
The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.Trans Am Clin Climatol Assoc. 2000;111:201-41. Trans Am Clin Climatol Assoc. 2000. PMID: 10881343 Free PMC article. Review.
-
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis.Curr Urol Rep. 2009 Jul;10(4):302-6. doi: 10.1007/s11934-009-0049-0. Curr Urol Rep. 2009. PMID: 19570492 Review.
-
Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.J Cancer. 2016 Feb 10;7(5):523-31. doi: 10.7150/jca.13821. eCollection 2016. J Cancer. 2016. PMID: 26958088 Free PMC article. Review.
-
Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.J Clin Lab Anal. 1998;12(4):242-9. doi: 10.1002/(sici)1098-2825(1998)12:4<242::aid-jcla9>3.0.co;2-9. J Clin Lab Anal. 1998. PMID: 9671177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous